The Tumultuous Fall of Hims & Hers: A Satirical Look at Telehealth Fluctuations
Prior to this disheartening disclosure, analysts held steadfastly optimistic forecasts, anticipating earnings of $0.23 per share and sales climbing to a commendable $552 million. Alas, our beleaguered company instead reported a meager $0.17 per share, accompanied by sales staggering below $545 million. A veritable feast of dashed hopes, one might say.